Delivery Order SPE2DB22D1106-SPE2DB25FEWK3
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,031.58 to AmerisourceBergen Drug Corp for Promethegan 25 mg suppositories (12-count) on August 21, 2025, with completion expected by August 22, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside contract with performance at the vendor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical...
- The Defense Logistics Agency awarded a $4,446.72 delivery order to AmerisourceBergen Drug Corp for Promethegan 25 mg suppositories (12 count) with a completion date of September 25, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, serves as the prime...
- The Defense Logistics Agency awarded a $7,329.92 delivery order to AmerisourceBergen Drug Corp for Promethegan 25 mg suppositories on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed price contract represents a non-set-aside competitive award to be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, fulfills this order as...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,004.03 firm fixed-price delivery order is for the supply of PROMETHEGAN 25 MG SUPPOSITORY 12S medical products. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical, which provides a comprehensive range of...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,679.75, is for the delivery of PROMETHEGAN 25 MG SUPPOSITORY 12S, a pharmaceutical product. The contract has a completion date of December 4, 2023, and is a firm fixed-price type with no set-aside requirements. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,510.02, is for the supply of 4567844138 PROMETHEGAN 25 MG SUPPOSITORY 12S. This order is not designated as a set-aside. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical...
- The Defense Logistics Agency awarded a $392.75 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 25 mg suppositories of Promethagan. As the prime contractor, Amerisourcebergen will deliver 12 units of the specified medication to a location in Conshohocken, Pennsylvania by September 7, 2023 to fulfill requirements under the contract. The single award was issued utilizing Amerisourcebergen's Prime Vendor Next contract vehicle, through which it provides pharmaceuticals and...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,500.96 on August 21, 2025, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed price contract, which is scheduled for completion by August 22, 2025, represents a child delivery order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was made through open competition with no...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $16,593.00 by the Defense Logistics Agency's Medical Supply Chain on August 25, 2025, with an ultimate completion date of August 26, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,240.16 by the Defense Logistics Agency's Medical Supply Chain on August 25, 2025. This firm fixed price contract, designated as a non-set-aside award, represents a child delivery order issued against AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FEWK3Delivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,608.02 for Promethegan 25 mg suppositories (12-count units) with an ultimate completion date of July 7, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 pharmaceutical prime vendor agreement running through December 2026 that enables the company to supply a comprehensive range of medications and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for the Defense Health Agency and military healthcare systems. The company's DLA prime contract encompasses specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains. This delivery order for Promethegan suppositories is consistent with AmerisourceBergen's extensive portfolio of pharmaceutical product deliveries through the DLA Medical Supply Chain, demonstrating the company's capability to fulfill federal medical supply requirements through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 7/5/25 |